About Us

About Us

Alphageneron Pharmaceuticals, Inc., is a privately-held clinical stage biotechnology company, developing targeted natural killer (NK) cell therapies which are supported by Companion Diagnostics. Alphageneron’s team is comprised of industry veterans with experience in both large pharma and biotechnology startups who are committed to transforming the lives of patients with cancer. The Company is based in Boston, Massachusetts with European capabilities in Munich, Germany.